Comparative Benchmarking
In the context of the broader market, OMER competes directly with industry leaders such as KALV and PCRX. With a market capitalization of $849.39M, it holds a significant position in the sector. When comparing efficiency, OMER's gross margin of N/A stands against KALV's 91.00% and PCRX's 72.26%. Such benchmarking helps identify whether Omeros Corp is trading at a premium or discount relative to its financial performance.
